1. Home
  2. MFA vs ABCL Comparison

MFA vs ABCL Comparison

Compare MFA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.42

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.16

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
ABCL
Founded
1997
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MFA
ABCL
Price
$9.42
$4.16
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$11.05
$8.40
AVG Volume (30 Days)
1.4M
8.1M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
14.16%
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.02
$21.85
P/E Ratio
$7.75
N/A
Revenue Growth
N/A
160.56
52 Week Low
$8.78
$1.94
52 Week High
$10.57
$6.52

Technical Indicators

Market Signals
Indicator
MFA
ABCL
Relative Strength Index (RSI) 39.44 47.01
Support Level $9.38 $3.96
Resistance Level $10.26 $4.84
Average True Range (ATR) 0.22 0.40
MACD -0.08 -0.08
Stochastic Oscillator 9.55 21.93

Price Performance

Historical Comparison
MFA
ABCL

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: